Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Sabela Ojea Shares of Denali Therapeutics on Friday fell after the company said the Phase 2 Himalaya study to treat patients with its amyotrophic lateral...
By Josh Beckerman Shares of G1 Therapeutics fell 46% to $2.44 in after-hours trading on Monday after the company provided an update to its Phase 3...
By Colin Kellaher KalVista Pharmaceuticals on Tuesday said a late-stage study of its proposed sebetralstat therapy for hereditary angioedema hit its key...
By Mike Cherney SYDNEY--Australia-based pharmaceutical company CSL said its Phase 3 study into whether its CSL112 drug reduced the risk of cardiovascular...
By Rob Curran Foghorn Therapeutics shares shot higher after the biotech company said Eli Lilly will conduct clinical trials of one of Foghorn's cancer...